NUTRITIONAL THERAPY IN A GERIATRIC PATIENT WITH ISCHEMIC STROKE, CHRONIC KIDNEY DISEASE, PNEUMONIA, AND DIABETES MELLITUS

  • Allysa Allysa Medical Doctor, Intan Husada Hospital, Tarogong,Tarogong Kidul, Garut Regency, West Java, Indonesia
  • Siti Nur Fatimah Department of Clinical Nutritions, Intan Husada Hospital, Tarogong Kidul, Garut Regency, West Java, Indonesia

Abstract

Stroke patients are often at risk of malnutrition and dehydration, conditions that can be exacerbated by comorbidities such as chronic kidney disease (CKD), pneumonia, and type II diabetes mellitus (DM II). Nutritional therapy is essential to improve nutritional status and support clinical and metabolic recovery in these patients. The aim of this article is to report the application and outcomes of nutritional therapy in a 62-year-old female patient with ischemic stroke, CKD, pneumonia, and type II diabetes mellitus. This is a case report of a 62-year-old woman diagnosed with ischemic stroke, pneumonia, CKD, and DM II. The patient presented with loss of consciousness (GCS score E2M2V2), left hemiparesis, and edema in the arms, sacral area, and pretibial region. Nutritional therapy was initiated with an initial caloric intake of 800 kcal, gradually increased to a target of 1800 kcal/day, tailored to the patient’s clinical condition and laboratory findings. The nutritional therapy began with 800 kcal/day and was gradually increased. Although the patient’s serum albumin levels improved from 2.49 g/dL to 2.85 g/dL, her kidney function continued to decline, with increasing levels of blood urea nitrogen, creatinine, C-reactive protein (CRP), and procalcitonin (PCT). The patient ultimately experienced cardiac arrest on the 29th day of treatment, and the family declined resuscitation efforts. Despite the nutritional therapy, the patient’s metabolic abnormalities could not be fully corrected without hemodialysis, which was declined by the family. The therapy provided some support but was insufficient to prevent the progression of renal failure and the patient’s subsequent death.


 


Keywords: chronic kidney disease, nutritional therapy, pneumonia, stroke, type II diabetes mellitus


DOI : 10.35990/mk.v9n1.p91-103

References

1. Feigin VL, Stark BA, Johnson CO, Roth GA, Bisignano C, Abady GG, et al. Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet Neurology. 2021;20(10):795-820.
2. Riskesdas LN. Kementerian Kesehatan RI Badan Penelitian dan Pengembangan Kesehatan. Jakarta; 2018.
3. Zhao Q, Yan T, Chopp M, Venkat P, Chen J. Brain–kidney interaction: renal dysfunction following ischemic stroke. Journal of Cerebral Blood Flow & Metabolism. 2020;40(2):246-62.
4. Robba C, Bonatti G, Battaglini D, Rocco PR, Pelosi P. Mechanical ventilation in patients with acute ischaemic stroke: from pathophysiology to clinical practice. Critical Care. 2019;23:1-14.
5. Kemenkes R. Pedoman Nasional Pelayanan Kedokteran Tatalaksana Diabetes Melitus Tipe 2 Dewasa. Jakarta: Kementerian Kesehatan RI. 2020.
6. Yoon J, Baek S, Jang Y, Lee CH, Lee ES, Byun H, et al. Malnutrition and associated factors in acute and subacute stroke patients with dysphagia. Nutrients. 2023;15(17):3739.
7. Grossmann I, Rodriguez K, Soni M, Joshi PK, Patel SC, Shreya D, et al. Stroke and pneumonia: mechanisms, risk factors, management, and prevention. Cureus. 2021;13(11).
8. Huppertz V, Guida S, Holdoway A, Strilciuc S, Baijens L, Schols JM, et al. Impaired nutritional condition after stroke from the hyperacute to the chronic phase: a systematic review and meta-analysis. Frontiers in neurology. 2022;12:780080.
9. Amalia L, Putri AA. Karakteristik Klinis dan Status Nutrisi pada Pasien Stroke Fase Akut. Jurnal Neuroanestesi Indonesia. 2022;11(1):1-6.
10.Stumpf F, Keller B, Gressies C, Schuetz P. Inflammation and nutrition: friend or foe? Nutrients. 2023;15(5):1159.
11.Zhou H, Wang A, Meng X, Lin J, Jiang Y, Jing J, et al. Low serum albumin levels predict poor outcome in patients with acute ischaemic stroke or transient ischaemic attack. Stroke and vascular neurology. 2021;6(3).
12.Kemenkes R. Pedoman Nasional Pelayanan Kedokteran (PNPK) Tata Laksana Malnutrisi Pada Dewasa. 2019.
13.Ikizler TA, Burrowes JD, Byham-Gray LD, Campbell KL, Carrero J-J, Chan W, et al. KDOQI clinical practice guideline for nutrition in CKD: 2020 update. American Journal of Kidney Diseases. 2020;76(3):S1-S107.
14.Pradhan N, Kerner J, Campos LA, Dobre M. Personalized Nutrition in Chronic Kidney Disease. Biomedicines. 2025;13(3):647.
15.de Boer IH, Khunti K, Sadusky T, Tuttle KR, Neumiller JJ, Rhee CM, et al. Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO). Diabetes care. 2022;45(12):3075-90.
16.Yamamoto S, Allen K, Jones KR, Cohen SS, Reyes K, Huhmann MB. Meeting calorie and protein needs in the critical care unit: A prospective observational pilot study. Nutrition and metabolic insights. 2020;13:1178638820905992.
17.Otis JL, Parker NM, Busch RA. Nutrition support for patients with renal dysfunction in the intensive care unit: A narrative review. Nutrition in Clinical Practice. 2025;40(1):35-53.
18.Ortiz-Prado E, Vasconez-Gonzalez J, Izquierdo-Condoy JS, Suárez-Sangucho IA, Prieto-Marín JG, Villarreal-Burbano KB, et al. Cholecalciferol (vitamin D3): efficacy, safety, and implications in public health. Frontiers in Nutrition. 2025;12:1579957.
19.Singer P, Blaser AR, Berger MM, Calder PC, Casaer M, Hiesmayr M, et al. ESPEN practical and partially revised guideline: clinical nutrition in the intensive care unit. Clinical Nutrition. 2023;42(9):1671-89.
20.Luo Y, Hao J, Su Z, Huang Y, Ye F, Qiu Y, et al. Prevalence and related factors of hypokalemia in patients with acute ischemic stroke. International Journal of General Medicine. 2024:5697-705.
21.Yuen KC, Sharf V, Smith E, Kim M, Yuen AS, MacDonald PR. Sodium and water perturbations in patients who had an acute stroke: clinical relevance and management strategies for the neurologist. Stroke and Vascular Neurology. 2022;7(3).
22.Guedes M, Robinson BM, Obrador G, Tong A, Pisoni RL, Pecoits-Filho R. Management of anemia in nondialysis chronic kidney disease: current recommendations, real-world practice, and patient perspectives. Kidney360. 2020;1(8):855-62.
23.S. S. C Reactive Protein as a Prognostic Indicator in Kidney Disease: A Prospective Study. Saran International Journal of Pharmaceutical and Clinical Research. 2024;10.
24.Osunbor OA, Unuigbe EI, Okaka EI, Adejumo OA. Protein energy wasting in pre-dialysis chronic kidney disease patients in Benin City, Nigeria: a cross-sectional study. Plos one. 2023;18(5):e0286075.
25.Abdel-Rahman EM, Hasan I, Abdelrazeq AS, Rawabdeh A, Liu M, Ghahramani N, et al. Early vs. Late Initiation of Dialysis in CKD Stage 5: Time for a Consensus. Kidney International Reports. 2024.
Published
2026-03-30
How to Cite
ALLYSA, Allysa; FATIMAH, Siti Nur. NUTRITIONAL THERAPY IN A GERIATRIC PATIENT WITH ISCHEMIC STROKE, CHRONIC KIDNEY DISEASE, PNEUMONIA, AND DIABETES MELLITUS. Medika Kartika : Jurnal Kedokteran dan Kesehatan, [S.l.], v. 9, n. 1, p. 91-103, mar. 2026. ISSN 2655-6537. Available at: <http://medikakartika.unjani.ac.id/medikakartika/index.php/mk/article/view/1274>. Date accessed: 13 apr. 2026.